{"id":146,"date":"2025-06-18T14:19:40","date_gmt":"2025-06-18T14:19:40","guid":{"rendered":"https:\/\/acinolatam.com\/news\/"},"modified":"2026-04-10T11:29:41","modified_gmt":"2026-04-10T11:29:41","slug":"news","status":"publish","type":"page","link":"https:\/\/acinolatam.com\/es\/news\/","title":{"rendered":"News"},"content":{"rendered":"<div id=\"news-archive-0\" class=\"news-archive acino-grid--first\" data-view=\"news-archive\"><div class=\"container article-container\"><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/leadership-announcements-and-new-arcera-structure\" class=\"block-link\"><strong class=\"text\">02.12.2024<\/strong><h2>Leadership Announcements and New Arcera Structure<\/h2><p class=\"text\">Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/acino-publishes-second-annual-sustainability-report\" class=\"block-link\"><strong class=\"text\">01.10.2024<\/strong><h2>Acino Publishes Second Annual Sustainability Report<\/h2><p class=\"text\">Report underscores Acino\u2019s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/acino-recognizes-world-heart-day-2024\" class=\"block-link\"><strong class=\"text\">29.09.2024<\/strong><h2>Acino Recognizes World Heart Day 2024<\/h2><p class=\"text\">Acino reaffirms its commitment to advancing cardiovascular health in emerging markets and beyond.<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/acino-signs-an-exclusive-agreement-with-lg-chem-for-novel-treatments-for-type-2-diabetes-and-osteoarthritis-in-latin-america\" class=\"block-link\"><strong class=\"text\">24.07.2024<\/strong><h2>Acino signs an exclusive agreement with LG Chem for Novel Treatments for Type 2 Diabetes and Osteoarthritis in Latin America<\/h2><p class=\"text\">Acino will market, commercialize, and distribute Hyruan One\u00ae in Brazil, and Zemiglo\u00ae and Zemimet\u00ae SR (Zemiduo\u00ae SR in Mexico) in&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/your-partner-for-innovative-medicines-in-emerging-markets\" class=\"block-link\"><strong class=\"text\">26.06.2024<\/strong><h2>Your partner for innovative medicines in emerging markets<\/h2><p class=\"text\">We have expanded our portfolio with several novel products, marking a significant step forward in our effort to help more&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/acino-signs-an-exclusive-license-agreement-with-supernus-in-latin-america\" class=\"block-link\"><strong class=\"text\">07.05.2024<\/strong><h2>Acino signs an exclusive license agreement with Supernus in Latin America<\/h2><p class=\"text\">Acino will collaborate with Supernus to develop and commercialize products for the treatment of diseases of the central nervous system&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/acino-announces-new-regional-leadership-and-hub-to-deliver-on-expanded-presence-and-capabilities-in-latin-america-following-m8-acquisition\" class=\"block-link\"><strong class=\"text\">02.04.2024<\/strong><h2>Acino announces new regional leadership and hub to deliver on expanded presence and capabilities in Latin America following M8 acquisition<\/h2><p class=\"text\">Joel Barlan has been appointed as Head of the LATAM region. Mexico City will now serve as a regional hub&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/acino-signs-an-exclusive-license-agreement-with-serb-pharmaceuticals-in-latin-america\" class=\"block-link\"><strong class=\"text\">20.03.2024<\/strong><h2>Acino signs an exclusive license agreement with SERB Pharmaceuticals in Latin America<\/h2><p class=\"text\">We are collaborating to bring an important orphan drug for cancer patients to Latin America.<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/es\/news\/article\/acino-completes-acquisition-of-m8-pharmaceuticals-significantly-expanding-presence-and-capabilities-in-latin-america\" class=\"block-link\"><strong class=\"text\">04.12.2023<\/strong><h2>Acino Completes Acquisition of M8 Pharmaceuticals Significantly Expanding Presence and Capabilities in Latin America<\/h2><p class=\"text\">Acino will enhance its presence in Latin America and strengthen its business through new partnerships, innovative and proven portfolio and&#8230;<\/p><\/a><\/article><\/div><div class=\"container button-container\"><button class=\"button accentFour-border load-more\" data-cat=\"18\" data-page=\"1\" data-max-pages=\"3\">Load More<\/button><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/news-archive.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-146","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/acinolatam.com\/es\/wp-json\/wp\/v2\/pages\/146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acinolatam.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/acinolatam.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/acinolatam.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/acinolatam.com\/es\/wp-json\/wp\/v2\/comments?post=146"}],"version-history":[{"count":6,"href":"https:\/\/acinolatam.com\/es\/wp-json\/wp\/v2\/pages\/146\/revisions"}],"predecessor-version":[{"id":2005,"href":"https:\/\/acinolatam.com\/es\/wp-json\/wp\/v2\/pages\/146\/revisions\/2005"}],"wp:attachment":[{"href":"https:\/\/acinolatam.com\/es\/wp-json\/wp\/v2\/media?parent=146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}